(NaturalNews) Occasionally, the laboratory efforts of research scientists contracted by Big Pharma produce side effect findings that are of interest to those of us who focus on natural preventative and healing remedies.
It appears that such an event occurred when the research team inadvertently reported vitamin D inhibiting a tumor growth factor in triple negative breast cancer cells, which tend to resist current conventional chemo therapies. Triple negative breast cancer is a very aggressive cancer, that often regroups after a short remission.
It
seems this team's focus and purpose was to help Big Pharma find another synthetic creation they could patent for big bucks to inhibit resistant cancer cells' ability to carry on and metastasize despite conventional therapies.
This research team's research was in vitro, which is test tube or petri dish analysis. But the breast cancer cells were cultured from actual breast cancer patients' cancerous tissues. During their process of tracking what enzymes or proteins did what, they used vitamin D to reduce
cathepsin L from cancer cells that refused to fold and quit.
They had determined that increased cathepsin L invaded the cell's nucleus and blocked 53 BPI, a protein that inhibits cancer cell growth. The 53 BPI protein flourished again when cathapsin L was reduced or eliminated, permitting this protein to resist the cancer cell's growth.
Note: Vitamin D was used to diminish the cancer cells' cathepsin L.That application
appears to have been part of an exercise in discovering and analyzing the mechanics within resistant
cancer cells for Big Pharma to formulate more toxic chemo agents. Vitamin D was not the focus of this research, although other news reports have featured the vitamin D3 for cancer aspect.
Various news reports and abstracts, taken from
The Journal of Cellular Biology, are in the sources below. However, the full write-up is available only for journal subscribers. It costs $30.00 for a two day look.
A broader look at vitamin D3 and cancer
Natural News has featured comprehensive coverage of vitamin D3 benefits, especially regarding cancer prevention and/or as an adjunct to alternative cancer therapies. Here's one
Natural News article that highlights nine major vitamin D benefits. (
http://www.naturalnews.com/035063_vitamin_D_cancer_facts.html)
In 2007, the Health Ranger, Mike Adams, exposed and explained why the cancer industry, including the
American Cancer Society and the
Susan G. Koman for Cure Foundation, decry vitamin D for cancer prevention. (
http://www.naturalnews.com/021892.html)
The 25[OH]D test (25 hydroxy vitamin D test) is the most accurate way to determine your vitamin D levels. The conventional normal of 30 ng/ml (30 nanograms per milliliter) is insufficient, according to holistic MDs, chiropractors, naturopaths, and independent nutritionists.
It's been recently discovered that 50 ng/ml or more provides much better disease prevention. From 80 to just under 100 ng/ml is recommended temporarily for therapeutic purposes.
Any cancer therapy should should exclude sugar and processed foods completely, while focusing on organic, whole plant foods.
Getting vitamin D3 from sunlight exposure or UVB tanning bed exposure guarantees you won't overdose vitamin D3. The body's D3 manufacturing system shuts down when there's enough.
Bathing immediately after sun exposure may remove skin oils that initiate the body's D3 manufacturing process. Wait longer or use soap only on unexposed skin.
Vitamin D3 cholicalciferol gel capsules will boost your D3 levels when there is a lack of sunshine or no access to a UVB ray tanning bed. From
5,000-10,000 international units (iu) daily is recommended if your levels aren't up to at least the 50 ng/ml mark.
The threshold for vitamin D3 toxicity, which is unlikely but possible, is 100 ng/ml. That's why looking into an inexpensive lab for the 25[OH]D test every six months or so would be wise.
Sources for this article include:http://jcb.rupress.org/content/200/2/127.full.pdfhttp://www.hindustantimes.comhttp://jcb.rupress.org/content/200/2/187.abstract
Have comments on this article? Post them here:
people have commented on this article.
Email this article to a friend
Now Available from 
